1 Durvalumab Market Overview 1.1 Product Overview and Scope of Durvalumab 1.2 Durvalumab Segment by Type 1.2.1 Global Durvalumab Market Value Comparison by Type (2023-2029) 1.2.2 2.4mL Injection 1.2.3 10mL Injection 1.3 Durvalumab Segment by Application 1.3.1 Global Durvalumab Market Value by Application: (2023-2029) 1.3.2 Locally Advanced Urothelial Carcinoma 1.3.3 Metastatic Urothelial Carcinoma 1.3.4 Other 1.4 Global Durvalumab Market Size Estimates and Forecasts 1.4.1 Global Durvalumab Revenue 2018-2029 1.4.2 Global Durvalumab Sales 2018-2029 1.4.3 Global Durvalumab Market Average Price (2018-2029) 1.5 Assumptions and Limitations 2 Durvalumab Market Competition by Manufacturers 2.1 Global Durvalumab Sales Market Share by Manufacturers (2018-2023) 2.2 Global Durvalumab Revenue Market Share by Manufacturers (2018-2023) 2.3 Global Durvalumab Average Price by Manufacturers (2018-2023) 2.4 Global Durvalumab Industry Ranking 2021 VS 2022 VS 2023 2.5 Global Key Manufacturers of Durvalumab, Manufacturing Sites & Headquarters 2.6 Global Key Manufacturers of Durvalumab, Product Type & Application 2.7 Durvalumab Market Competitive Situation and Trends 2.7.1 Durvalumab Market Concentration Rate 2.7.2 The Global Top 5 and Top 10 Largest Durvalumab Players Market Share by Revenue 2.7.3 Global Durvalumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Durvalumab Retrospective Market Scenario by Region 3.1 Global Durvalumab Market Size by Region: 2018 Versus 2022 Versus 2029 3.2 Global Durvalumab Global Durvalumab Sales by Region: 2018-2029 3.2.1 Global Durvalumab Sales by Region: 2018-2023 3.2.2 Global Durvalumab Sales by Region: 2024-2029 3.3 Global Durvalumab Global Durvalumab Revenue by Region: 2018-2029 3.3.1 Global Durvalumab Revenue by Region: 2018-2023 3.3.2 Global Durvalumab Revenue by Region: 2024-2029 3.4 North America Durvalumab Market Facts & Figures by Country 3.4.1 North America Durvalumab Market Size by Country: 2018 VS 2022 VS 2029 3.4.2 North America Durvalumab Sales by Country (2018-2029) 3.4.3 North America Durvalumab Revenue by Country (2018-2029) 3.4.4 U.S. 3.4.5 Canada 3.5 Europe Durvalumab Market Facts & Figures by Country 3.5.1 Europe Durvalumab Market Size by Country: 2018 VS 2022 VS 2029 3.5.2 Europe Durvalumab Sales by Country (2018-2029) 3.5.3 Europe Durvalumab Revenue by Country (2018-2029) 3.5.4 Germany 3.5.5 France 3.5.6 U.K. 3.5.7 Italy 3.5.8 Russia 3.6 Asia Pacific Durvalumab Market Facts & Figures by Country 3.6.1 Asia Pacific Durvalumab Market Size by Country: 2018 VS 2022 VS 2029 3.6.2 Asia Pacific Durvalumab Sales by Country (2018-2029) 3.6.3 Asia Pacific Durvalumab Revenue by Country (2018-2029) 3.6.4 China 3.6.5 Japan 3.6.6 South Korea 3.6.7 India 3.6.8 Australia 3.6.9 Taiwan 3.6.10 Indonesia 3.6.11 Thailand 3.6.12 Malaysia 3.6.13 Philippines 3.7 Latin America Durvalumab Market Facts & Figures by Country 3.7.1 Latin America Durvalumab Market Size by Country: 2018 VS 2022 VS 2029 3.7.2 Latin America Durvalumab Sales by Country (2018-2029) 3.7.3 Latin America Durvalumab Revenue by Country (2018-2029) 3.7.4 Mexico 3.7.5 Brazil 3.7.6 Argentina 3.8 Middle East and Africa Durvalumab Market Facts & Figures by Country 3.8.1 Middle East and Africa Durvalumab Market Size by Country: 2018 VS 2022 VS 2029 3.8.2 Middle East and Africa Durvalumab Sales by Country (2018-2029) 3.8.3 Middle East and Africa Durvalumab Revenue by Country (2018-2029) 3.8.4 Turkey 3.8.5 Saudi Arabia 3.8.6 U.A.E 4 Segment by Type 4.1 Global Durvalumab Sales by Type (2018-2029) 4.1.1 Global Durvalumab Sales by Type (2018-2023) 4.1.2 Global Durvalumab Sales by Type (2024-2029) 4.1.3 Global Durvalumab Sales Market Share by Type (2018-2029) 4.2 Global Durvalumab Revenue by Type (2018-2029) 4.2.1 Global Durvalumab Revenue by Type (2018-2023) 4.2.2 Global Durvalumab Revenue by Type (2024-2029) 4.2.3 Global Durvalumab Revenue Market Share by Type (2018-2029) 4.3 Global Durvalumab Price by Type (2018-2029) 5 Segment by Application 5.1 Global Durvalumab Sales by Application (2018-2029) 5.1.1 Global Durvalumab Sales by Application (2018-2023) 5.1.2 Global Durvalumab Sales by Application (2024-2029) 5.1.3 Global Durvalumab Sales Market Share by Application (2018-2029) 5.2 Global Durvalumab Revenue by Application (2018-2029) 5.2.1 Global Durvalumab Revenue by Application (2018-2023) 5.2.2 Global Durvalumab Revenue by Application (2024-2029) 5.2.3 Global Durvalumab Revenue Market Share by Application (2018-2029) 5.3 Global Durvalumab Price by Application (2018-2029) 6 Key Companies Profiled 6.1 Medimmune (AstraZeneca) 6.1.1 Medimmune (AstraZeneca) Corporation Information 6.1.2 Medimmune (AstraZeneca) Description and Business Overview 6.1.3 Medimmune (AstraZeneca) Durvalumab Sales, Revenue and Gross Margin (2018-2023) 6.1.4 Medimmune (AstraZeneca) Durvalumab Product Portfolio 6.1.5 Medimmune (AstraZeneca) Recent Developments/Updates 7 Industry Chain and Sales Channels Analysis 7.1 Durvalumab Industry Chain Analysis 7.2 Durvalumab Key Raw Materials 7.2.1 Key Raw Materials 7.2.2 Raw Materials Key Suppliers 7.3 Durvalumab Production Mode & Process 7.4 Durvalumab Sales and Marketing 7.4.1 Durvalumab Sales Channels 7.4.2 Durvalumab Distributors 7.5 Durvalumab Customers 8 Durvalumab Market Dynamics 8.1 Durvalumab Industry Trends 8.2 Durvalumab Market Drivers 8.3 Durvalumab Market Challenges 8.4 Durvalumab Market Restraints 9 Research Finding and Conclusion 10 Methodology and Data Source 10.1 Methodology/Research Approach 10.1.1 Research Programs/Design 10.1.2 Market Size Estimation 10.1.3 Market Breakdown and Data Triangulation 10.2 Data Source 10.2.1 Secondary Sources 10.2.2 Primary Sources 10.3 Author List 10.4 Disclaimer

List of Tables Table 1. Global Durvalumab Market Value Comparison by Type (2023-2029) & (US$ Million) Table 2. Global Durvalumab Market Value Comparison by Application (2023-2029) & (US$ Million) Table 3. Global Durvalumab Market Competitive Situation by Manufacturers in 2022 Table 4. Global Durvalumab Sales (K Pcs) of Key Manufacturers (2018-2023) Table 5. Global Durvalumab Sales Market Share by Manufacturers (2018-2023) Table 6. Global Durvalumab Revenue (US$ Million) by Manufacturers (2018-2023) Table 7. Global Durvalumab Revenue Share by Manufacturers (2018-2023) Table 8. Global Market Durvalumab Average Price (USD/Pcs) of Key Manufacturers (2018-2023) Table 9. Global Key Players of Durvalumab, Industry Ranking, 2021 VS 2022 VS 2023 Table 10. Global Key Manufacturers of Durvalumab, Manufacturing Sites & Headquarters Table 11. Global Key Manufacturers of Durvalumab, Product Type & Application Table 12. Global Key Manufacturers of Durvalumab, Date of Enter into This Industry Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Durvalumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Durvalumab as of 2022) Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans Table 16. Global Durvalumab Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 17. Global Durvalumab Sales by Region (2018-2023) & (K Pcs) Table 18. Global Durvalumab Sales Market Share by Region (2018-2023) Table 19. Global Durvalumab Sales by Region (2024-2029) & (K Pcs) Table 20. Global Durvalumab Sales Market Share by Region (2024-2029) Table 21. Global Durvalumab Revenue by Region (2018-2023) & (US$ Million) Table 22. Global Durvalumab Revenue Market Share by Region (2018-2023) Table 23. Global Durvalumab Revenue by Region (2024-2029) & (US$ Million) Table 24. Global Durvalumab Revenue Market Share by Region (2024-2029) Table 25. North America Durvalumab Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 26. North America Durvalumab Sales by Country (2018-2023) & (K Pcs) Table 27. North America Durvalumab Sales by Country (2024-2029) & (K Pcs) Table 28. North America Durvalumab Revenue by Country (2018-2023) & (US$ Million) Table 29. North America Durvalumab Revenue by Country (2024-2029) & (US$ Million) Table 30. Europe Durvalumab Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 31. Europe Durvalumab Sales by Country (2018-2023) & (K Pcs) Table 32. Europe Durvalumab Sales by Country (2024-2029) & (K Pcs) Table 33. Europe Durvalumab Revenue by Country (2018-2023) & (US$ Million) Table 34. Europe Durvalumab Revenue by Country (2024-2029) & (US$ Million) Table 35. Asia Pacific Durvalumab Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million) Table 36. Asia Pacific Durvalumab Sales by Region (2018-2023) & (K Pcs) Table 37. Asia Pacific Durvalumab Sales by Region (2024-2029) & (K Pcs) Table 38. Asia Pacific Durvalumab Revenue by Region (2018-2023) & (US$ Million) Table 39. Asia Pacific Durvalumab Revenue by Region (2024-2029) & (US$ Million) Table 40. Latin America Durvalumab Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 41. Latin America Durvalumab Sales by Country (2018-2023) & (K Pcs) Table 42. Latin America Durvalumab Sales by Country (2024-2029) & (K Pcs) Table 43. Latin America Durvalumab Revenue by Country (2018-2023) & (US$ Million) Table 44. Latin America Durvalumab Revenue by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Durvalumab Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 46. Middle East & Africa Durvalumab Sales by Country (2018-2023) & (K Pcs) Table 47. Middle East & Africa Durvalumab Sales by Country (2024-2029) & (K Pcs) Table 48. Middle East & Africa Durvalumab Revenue by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Durvalumab Revenue by Country (2024-2029) & (US$ Million) Table 50. Global Durvalumab Sales (K Pcs) by Type (2018-2023) Table 51. Global Durvalumab Sales (K Pcs) by Type (2024-2029) Table 52. Global Durvalumab Sales Market Share by Type (2018-2023) Table 53. Global Durvalumab Sales Market Share by Type (2024-2029) Table 54. Global Durvalumab Revenue (US$ Million) by Type (2018-2023) Table 55. Global Durvalumab Revenue (US$ Million) by Type (2024-2029) Table 56. Global Durvalumab Revenue Market Share by Type (2018-2023) Table 57. Global Durvalumab Revenue Market Share by Type (2024-2029) Table 58. Global Durvalumab Price (USD/Pcs) by Type (2018-2023) Table 59. Global Durvalumab Price (USD/Pcs) by Type (2024-2029) Table 60. Global Durvalumab Sales (K Pcs) by Application (2018-2023) Table 61. Global Durvalumab Sales (K Pcs) by Application (2024-2029) Table 62. Global Durvalumab Sales Market Share by Application (2018-2023) Table 63. Global Durvalumab Sales Market Share by Application (2024-2029) Table 64. Global Durvalumab Revenue (US$ Million) by Application (2018-2023) Table 65. Global Durvalumab Revenue (US$ Million) by Application (2024-2029) Table 66. Global Durvalumab Revenue Market Share by Application (2018-2023) Table 67. Global Durvalumab Revenue Market Share by Application (2024-2029) Table 68. Global Durvalumab Price (USD/Pcs) by Application (2018-2023) Table 69. Global Durvalumab Price (USD/Pcs) by Application (2024-2029) Table 70. Medimmune (AstraZeneca) Corporation Information Table 71. Medimmune (AstraZeneca) Description and Business Overview Table 72. Medimmune (AstraZeneca) Durvalumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023) Table 73. Medimmune (AstraZeneca) Durvalumab Product Table 74. Medimmune (AstraZeneca) Recent Developments/Updates Table 75. Key Raw Materials Lists Table 76. Raw Materials Key Suppliers Lists Table 77. Durvalumab Distributors List Table 78. Durvalumab Customers List Table 79. Durvalumab Market Trends Table 80. Durvalumab Market Drivers Table 81. Durvalumab Market Challenges Table 82. Durvalumab Market Restraints Table 83. Research Programs/Design for This Report Table 84. Key Data Information from Secondary Sources Table 85. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Durvalumab Figure 2. Global Durvalumab Market Value Comparison by Type (2023-2029) & (US$ Million) Figure 3. Global Durvalumab Market Share by Type in 2022 & 2029 Figure 4. 2.4mL Injection Product Picture Figure 5. 10mL Injection Product Picture Figure 6. Global Durvalumab Market Value Comparison by Application (2023-2029) & (US$ Million) Figure 7. Global Durvalumab Market Share by Application in 2022 & 2029 Figure 8. Locally Advanced Urothelial Carcinoma Figure 9. Metastatic Urothelial Carcinoma Figure 10. Other Figure 11. Global Durvalumab Revenue, (US$ Million), 2018 VS 2022 VS 2029 Figure 12. Global Durvalumab Market Size (2018-2029) & (US$ Million) Figure 13. Global Durvalumab Sales (2018-2029) & (K Pcs) Figure 14. Global Durvalumab Average Price (USD/Pcs) & (2018-2029) Figure 15. Durvalumab Report Years Considered Figure 16. Durvalumab Sales Share by Manufacturers in 2022 Figure 17. Global Durvalumab Revenue Share by Manufacturers in 2022 Figure 18. The Global 5 and 10 Largest Durvalumab Players: Market Share by Revenue in 2022 Figure 19. Durvalumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022 Figure 20. Global Durvalumab Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Figure 21. North America Durvalumab Sales Market Share by Country (2018-2029) Figure 22. North America Durvalumab Revenue Market Share by Country (2018-2029) Figure 23. U.S. Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 24. Canada Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 25. Europe Durvalumab Sales Market Share by Country (2018-2029) Figure 26. Europe Durvalumab Revenue Market Share by Country (2018-2029) Figure 27. Germany Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 28. France Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 29. U.K. Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 30. Italy Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 31. Russia Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 32. Asia Pacific Durvalumab Sales Market Share by Region (2018-2029) Figure 33. Asia Pacific Durvalumab Revenue Market Share by Region (2018-2029) Figure 34. China Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 35. Japan Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 36. South Korea Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 37. India Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 38. Australia Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 39. Taiwan Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 40. Indonesia Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 41. Thailand Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 42. Malaysia Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 43. Philippines Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 44. Latin America Durvalumab Sales Market Share by Country (2018-2029) Figure 45. Latin America Durvalumab Revenue Market Share by Country (2018-2029) Figure 46. Mexico Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 47. Brazil Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 48. Argentina Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 49. Middle East & Africa Durvalumab Sales Market Share by Country (2018-2029) Figure 50. Middle East & Africa Durvalumab Revenue Market Share by Country (2018-2029) Figure 51. Turkey Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 52. Saudi Arabia Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 53. U.A.E Durvalumab Revenue Growth Rate (2018-2029) & (US$ Million) Figure 54. Global Sales Market Share of Durvalumab by Type (2018-2029) Figure 55. Global Revenue Market Share of Durvalumab by Type (2018-2029) Figure 56. Global Durvalumab Price (USD/Pcs) by Type (2018-2029) Figure 57. Global Sales Market Share of Durvalumab by Application (2018-2029) Figure 58. Global Revenue Market Share of Durvalumab by Application (2018-2029) Figure 59. Global Durvalumab Price (USD/Pcs) by Application (2018-2029) Figure 60. Durvalumab Value Chain Figure 61. Durvalumab Production Process Figure 62. Channels of Distribution (Direct Vs Distribution) Figure 63. Distributors Profiles Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Medimmune (AstraZeneca)